USA Oncology Drug Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Oncology Drug market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Oncology Drug market. Detailed analysis of key players, along with key growth strategies adopted by Oncology Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Glaxosmithkline Plc

    • Bristol-Myers Squibb

    • Sanofi

    • Roche Ltd

    • Astra Zenca Plc

    • Celgene Corporation

    • Abbvie, Inc

    • Johnson & Johnson

    • Merck & Co

    • Novartis AG

    • Pfizer Inc

    • Amgen Inc

    • Eli Lilly And Company

    By Type:

    • Chemotherapy

    • Targeted Therapy

    • Immunotherapy

    • Hormonal Therapy

    • Others

    By End-User:

    • Blood Cancer

    • Breast Cancer

    • gastrointestinal Tract Cancer

    • Prostate Cancer

    • Lung Cancer

    • Skin Cancer

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Oncology Drug Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Oncology Drug Market Size and Growth Rate of Chemotherapy from 2016 to 2027

      • 1.3.2 USA Oncology Drug Market Size and Growth Rate of Targeted Therapy from 2016 to 2027

      • 1.3.3 USA Oncology Drug Market Size and Growth Rate of Immunotherapy from 2016 to 2027

      • 1.3.4 USA Oncology Drug Market Size and Growth Rate of Hormonal Therapy from 2016 to 2027

      • 1.3.5 USA Oncology Drug Market Size and Growth Rate of Others from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Oncology Drug Market Size and Growth Rate of Blood Cancer from 2016 to 2027

      • 1.4.2 USA Oncology Drug Market Size and Growth Rate of Breast Cancer from 2016 to 2027

      • 1.4.3 USA Oncology Drug Market Size and Growth Rate of gastrointestinal Tract Cancer from 2016 to 2027

      • 1.4.4 USA Oncology Drug Market Size and Growth Rate of Prostate Cancer from 2016 to 2027

      • 1.4.5 USA Oncology Drug Market Size and Growth Rate of Lung Cancer from 2016 to 2027

      • 1.4.6 USA Oncology Drug Market Size and Growth Rate of Skin Cancer from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Oncology Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Oncology Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Oncology Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Oncology Drug Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Oncology Drug Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Oncology Drug by Major Types

      • 3.4.1 Market Size and Growth Rate of Chemotherapy

      • 3.4.2 Market Size and Growth Rate of Targeted Therapy

      • 3.4.3 Market Size and Growth Rate of Immunotherapy

      • 3.4.4 Market Size and Growth Rate of Hormonal Therapy

      • 3.4.5 Market Size and Growth Rate of Others

    4 Segmentation of Oncology Drug Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Oncology Drug by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Oncology Drug in Blood Cancer

      • 4.4.2 Market Size and Growth Rate of Oncology Drug in Breast Cancer

      • 4.4.3 Market Size and Growth Rate of Oncology Drug in gastrointestinal Tract Cancer

      • 4.4.4 Market Size and Growth Rate of Oncology Drug in Prostate Cancer

      • 4.4.5 Market Size and Growth Rate of Oncology Drug in Lung Cancer

      • 4.4.6 Market Size and Growth Rate of Oncology Drug in Skin Cancer

    5 Market Analysis by Regions

    • 5.1 USA Oncology Drug Production Analysis by Regions

    • 5.2 USA Oncology Drug Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Oncology Drug Landscape Analysis

    • 6.1 West USA Oncology Drug Landscape Analysis by Major Types

    • 6.2 West USA Oncology Drug Landscape Analysis by Major End-Users

    7 South USA Oncology Drug Landscape Analysis

    • 7.1 South USA Oncology Drug Landscape Analysis by Major Types

    • 7.2 South USA Oncology Drug Landscape Analysis by Major End-Users

    8 Middle West USA Oncology Drug Landscape Analysis

    • 8.1 Middle West USA Oncology Drug Landscape Analysis by Major Types

    • 8.2 Middle West USA Oncology Drug Landscape Analysis by Major End-Users

    9 Northeast USA Oncology Drug Landscape Analysis

    • 9.1 Northeast USA Oncology Drug Landscape Analysis by Major Types

    • 9.2 Northeast USA Oncology Drug Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Glaxosmithkline Plc

        • 10.1.1 Glaxosmithkline Plc Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Bristol-Myers Squibb

        • 10.2.1 Bristol-Myers Squibb Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Sanofi

        • 10.3.1 Sanofi Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Roche Ltd

        • 10.4.1 Roche Ltd Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Astra Zenca Plc

        • 10.5.1 Astra Zenca Plc Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Celgene Corporation

        • 10.6.1 Celgene Corporation Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Abbvie, Inc

        • 10.7.1 Abbvie, Inc Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Johnson & Johnson

        • 10.8.1 Johnson & Johnson Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Merck & Co

        • 10.9.1 Merck & Co Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Novartis AG

        • 10.10.1 Novartis AG Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 Pfizer Inc

        • 10.11.1 Pfizer Inc Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

      • 10.12 Amgen Inc

        • 10.12.1 Amgen Inc Company Profile and Recent Development

        • 10.12.2 Market Performance

        • 10.12.3 Product and Service Introduction

      • 10.13 Eli Lilly And Company

        • 10.13.1 Eli Lilly And Company Company Profile and Recent Development

        • 10.13.2 Market Performance

        • 10.13.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Oncology Drug Market Size and Growth Rate of Chemotherapy from 2016 to 2027

    • Figure USA Oncology Drug Market Size and Growth Rate of Targeted Therapy from 2016 to 2027

    • Figure USA Oncology Drug Market Size and Growth Rate of Immunotherapy from 2016 to 2027

    • Figure USA Oncology Drug Market Size and Growth Rate of Hormonal Therapy from 2016 to 2027

    • Figure USA Oncology Drug Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Oncology Drug Market Size and Growth Rate of Blood Cancer from 2016 to 2027

    • Figure USA Oncology Drug Market Size and Growth Rate of Breast Cancer from 2016 to 2027

    • Figure USA Oncology Drug Market Size and Growth Rate of gastrointestinal Tract Cancer from 2016 to 2027

    • Figure USA Oncology Drug Market Size and Growth Rate of Prostate Cancer from 2016 to 2027

    • Figure USA Oncology Drug Market Size and Growth Rate of Lung Cancer from 2016 to 2027

    • Figure USA Oncology Drug Market Size and Growth Rate of Skin Cancer from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Oncology Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Oncology Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Oncology Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Oncology Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Oncology Drug Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Oncology Drug

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Oncology Drug by Different Types from 2016 to 2027

    • Table Consumption Share of Oncology Drug by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Chemotherapy

    • Figure Market Size and Growth Rate of Targeted Therapy

    • Figure Market Size and Growth Rate of Immunotherapy

    • Figure Market Size and Growth Rate of Hormonal Therapy

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Oncology Drug by Different End-Users from 2016 to 2027

    • Table Consumption Share of Oncology Drug by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Blood Cancer

    • Figure Market Size and Growth Rate of Breast Cancer

    • Figure Market Size and Growth Rate of gastrointestinal Tract Cancer

    • Figure Market Size and Growth Rate of Prostate Cancer

    • Figure Market Size and Growth Rate of Lung Cancer

    • Figure Market Size and Growth Rate of Skin Cancer

    • Table USA Oncology Drug Production by Regions

    • Table USA Oncology Drug Production Share by Regions

    • Figure USA Oncology Drug Production Share by Regions in 2016

    • Figure USA Oncology Drug Production Share by Regions in 2021

    • Figure USA Oncology Drug Production Share by Regions in 2027

    • Table USA Oncology Drug Consumption by Regions

    • Table USA Oncology Drug Consumption Share by Regions

    • Figure USA Oncology Drug Consumption Share by Regions in 2016

    • Figure USA Oncology Drug Consumption Share by Regions in 2021

    • Figure USA Oncology Drug Consumption Share by Regions in 2027

    • Table West USA Oncology Drug Consumption by Types from 2016 to 2027

    • Table West USA Oncology Drug Consumption Share by Types from 2016 to 2027

    • Figure West USA Oncology Drug Consumption Share by Types in 2016

    • Figure West USA Oncology Drug Consumption Share by Types in 2021

    • Figure West USA Oncology Drug Consumption Share by Types in 2027

    • Table West USA Oncology Drug Consumption by End-Users from 2016 to 2027

    • Table West USA Oncology Drug Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Oncology Drug Consumption Share by End-Users in 2016

    • Figure West USA Oncology Drug Consumption Share by End-Users in 2021

    • Figure West USA Oncology Drug Consumption Share by End-Users in 2027

    • Table South USA Oncology Drug Consumption by Types from 2016 to 2027

    • Table South USA Oncology Drug Consumption Share by Types from 2016 to 2027

    • Figure South USA Oncology Drug Consumption Share by Types in 2016

    • Figure South USA Oncology Drug Consumption Share by Types in 2021

    • Figure South USA Oncology Drug Consumption Share by Types in 2027

    • Table South USA Oncology Drug Consumption by End-Users from 2016 to 2027

    • Table South USA Oncology Drug Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Oncology Drug Consumption Share by End-Users in 2016

    • Figure South USA Oncology Drug Consumption Share by End-Users in 2021

    • Figure South USA Oncology Drug Consumption Share by End-Users in 2027

    • Table Middle West USA Oncology Drug Consumption by Types from 2016 to 2027

    • Table Middle West USA Oncology Drug Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Oncology Drug Consumption Share by Types in 2016

    • Figure Middle West USA Oncology Drug Consumption Share by Types in 2021

    • Figure Middle West USA Oncology Drug Consumption Share by Types in 2027

    • Table Middle West USA Oncology Drug Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Oncology Drug Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Oncology Drug Consumption Share by End-Users in 2016

    • Figure Middle West USA Oncology Drug Consumption Share by End-Users in 2021

    • Figure Middle West USA Oncology Drug Consumption Share by End-Users in 2027

    • Table Northeast USA Oncology Drug Consumption by Types from 2016 to 2027

    • Table Northeast USA Oncology Drug Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Oncology Drug Consumption Share by Types in 2016

    • Figure Northeast USA Oncology Drug Consumption Share by Types in 2021

    • Figure Northeast USA Oncology Drug Consumption Share by Types in 2027

    • Table Northeast USA Oncology Drug Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Oncology Drug Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Oncology Drug Consumption Share by End-Users in 2016

    • Figure Northeast USA Oncology Drug Consumption Share by End-Users in 2021

    • Figure Northeast USA Oncology Drug Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Glaxosmithkline Plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Glaxosmithkline Plc

    • Figure Sales and Growth Rate Analysis of Glaxosmithkline Plc

    • Figure Revenue and Market Share Analysis of Glaxosmithkline Plc

    • Table Product and Service Introduction of Glaxosmithkline Plc

    • Table Company Profile and Development Status of Bristol-Myers Squibb

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb

    • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb

    • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb

    • Table Product and Service Introduction of Bristol-Myers Squibb

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Roche Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche Ltd

    • Figure Sales and Growth Rate Analysis of Roche Ltd

    • Figure Revenue and Market Share Analysis of Roche Ltd

    • Table Product and Service Introduction of Roche Ltd

    • Table Company Profile and Development Status of Astra Zenca Plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astra Zenca Plc

    • Figure Sales and Growth Rate Analysis of Astra Zenca Plc

    • Figure Revenue and Market Share Analysis of Astra Zenca Plc

    • Table Product and Service Introduction of Astra Zenca Plc

    • Table Company Profile and Development Status of Celgene Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene Corporation

    • Figure Sales and Growth Rate Analysis of Celgene Corporation

    • Figure Revenue and Market Share Analysis of Celgene Corporation

    • Table Product and Service Introduction of Celgene Corporation

    • Table Company Profile and Development Status of Abbvie, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbvie, Inc

    • Figure Sales and Growth Rate Analysis of Abbvie, Inc

    • Figure Revenue and Market Share Analysis of Abbvie, Inc

    • Table Product and Service Introduction of Abbvie, Inc

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of Merck & Co

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co

    • Figure Sales and Growth Rate Analysis of Merck & Co

    • Figure Revenue and Market Share Analysis of Merck & Co

    • Table Product and Service Introduction of Merck & Co

    • Table Company Profile and Development Status of Novartis AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG

    • Figure Sales and Growth Rate Analysis of Novartis AG

    • Figure Revenue and Market Share Analysis of Novartis AG

    • Table Product and Service Introduction of Novartis AG

    • Table Company Profile and Development Status of Pfizer Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc

    • Figure Sales and Growth Rate Analysis of Pfizer Inc

    • Figure Revenue and Market Share Analysis of Pfizer Inc

    • Table Product and Service Introduction of Pfizer Inc

    • Table Company Profile and Development Status of Amgen Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen Inc

    • Figure Sales and Growth Rate Analysis of Amgen Inc

    • Figure Revenue and Market Share Analysis of Amgen Inc

    • Table Product and Service Introduction of Amgen Inc

    • Table Company Profile and Development Status of Eli Lilly And Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly And Company

    • Figure Sales and Growth Rate Analysis of Eli Lilly And Company

    • Figure Revenue and Market Share Analysis of Eli Lilly And Company

    • Table Product and Service Introduction of Eli Lilly And Company


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.